How lobbyists did in the health care debate

The Post reports on different views on lobbyists’ wins and losses in the health care reform debate.

Either way, pharmaceutical lobbyists won new federal policies they coveted and set a trajectory for long-term industry growth. Privately, several of them say their biggest triumph was heading off Democrats led by Rep. Henry Waxman, D-Calif., who wanted even more money from their industry to finance the health care system’s expansion.

Comments are closed.